Drugs / HPV E7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02947854 | Sep 2016 → Mar 2018 | — | PCI Biotech AS | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPV E7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02947854 ↗ |
| Known as | Human Papilloma Virus E7 | “HPV E7 (Human Papilloma Virus E7) peptides” NCT02947854 ↗ |
| Modality | Peptide | “HPV16 E7 peptide antigens” PMID 33488576 ↗ Jan 2021 |